Explore the Frontier of Global Academia

AcademicHub aggregates real-time literature from top journals and preprint platforms. Build your personal research radar and let large language models compile cross-disciplinary analysis briefings automatically.

Authors: Julio Rosenstock ×

↻ Shuffle

01.

Nature Medicine 2026-06-24 DOI: HASH:8ced04b4d4cf9058f0ad37dd5ac1fa5a

Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial

Authors:

Julio Rosenstock ↗

No abstract for this item (typically a correction, editorial or news piece — the publisher provides none)

Read & Discuss → View Source →